Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06853132

Baduanjin With Resistance Training Program

Baduanjin With Resistance Training Program for Elderly Patients With Osteoporosis and Lumbar Disc Herniation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to improve symptoms of Lumbar Disc Herniation (LDH) and Osteoporosis (OP) by implementing an evidence-based Baduanjin exercise to reduce pain and increase muscle strength and quality of life in Chinese patients. This study will provide new sights of exercise of elderly patients with LDH and OP for elderly patients.

Detailed description

Participants in the control group will continue with their conventional post surgery treatment as follows: comprehensive post-operative care and educational handouts that include guidelines for lumbar and back exercises to improve recovery and promote spinal health. In addition, participants will receive three interactive Q\&A sessions before discharge (pre-operation, post-operation, and on the day of discharge). During these sessions, patients can discuss their concerns and ask questions about their recovery. Participants in the experimental group will continue to receive their conventional post surgery treatment in addition to BDJ as follows: Individual session training (admission to week 1 post-surgery), no training week 2, Group session I (week 3 and 4), Group session 2 (week 5-12) and perform independent exercises during which participants will have to keep an exercise diary (week 13-24). Data collection will be conducted through in-person visits at baseline and Week 1, followed by phone calls at Week 12 and Week 24.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBaduanjin with Resistance Training ProgramBaduanjin with Resistance Training Program

Timeline

Start date
2025-08-30
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2025-02-28
Last updated
2025-11-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06853132. Inclusion in this directory is not an endorsement.